Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Research

Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function

Authors: Meili Yang, Peihong Chen, Hua Jin, Xinmiao Xie, Ting Gao, Lili Yang, Xuemei Yu

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Background

Irisin is a novel myokine secreted in response to peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) activation through exercise. The first-degree relatives (FDRs) of type 2 diabetes mellitus (T2DM) patients bear a lifetime risk for developing T2DM, especially after 40 years old. However, the circulating irisin levels in middle-aged FDRs of T2DM is unclear. We therefore investigated the association between circulating irisin and pancreatic β-cell function in normal-glucose-tolerance (NGT) subjects.

Methods

In this cross-sectional study, we recruited 412 supposed healthy subjects aged 40-60 who were FDRs of T2DM patients but without previous diagnosis of T2DM. Of the 412 individuals, 254 had NGT and 60 were newly diagnosed T2DM based on the results of a 75 g oral glucose tolerance test (OGTT- World Health Organization diagnostic criteria). We measured irisin in the newly diagnosed T2DM group (n = 60) and in an age- and sex-matched NGT subgroups (n = 62). Serum irisin was quantified by ELISA, and its association with metabolic parameters was analysed by Pearson’s correlation and multiple linear regression analyses.

Results

There was no significant difference in serum irisin between middle-aged newly diagnosed T2DM patients and the NGT control group. Circulating irisin was correlated with haemoglobin A1c (r = 0.202, p = 0.026) and estimated glomerular filtration rate (r = 0.239, p = 0.010). Multiple linear regression revealed that only homeostasis model assessment-β (HOMA-β) was associated with irisin in NGT subjects after adjusting for confounding factors. However, similar analysis in T2DM did not reveal a significant association between circulating irisin and metabolic parameters.

Conclusions

There was no significant difference in serum irisin between middle-aged newly diagnosed T2DM patients and the NGT controls. Serum irisin level was closely related to HOMA-β in NGT, suggesting that irisin may play a crucial role in pancreatic β-cell function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, et al: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010, 42: 579-589. 10.1038/ng.609.PubMedCentralCrossRefPubMed Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, et al: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010, 42: 579-589. 10.1038/ng.609.PubMedCentralCrossRefPubMed
2.
go back to reference Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes. 1997, 46: 1001-1009. 10.2337/diab.46.6.1001.CrossRefPubMed Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes. 1997, 46: 1001-1009. 10.2337/diab.46.6.1001.CrossRefPubMed
3.
go back to reference Meigs JB, Cupples LA, Wilson PW: Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes. 2000, 49: 2201-2207. 10.2337/diabetes.49.12.2201.CrossRefPubMed Meigs JB, Cupples LA, Wilson PW: Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes. 2000, 49: 2201-2207. 10.2337/diabetes.49.12.2201.CrossRefPubMed
4.
go back to reference Alibegovic AC, Højbjerre L, Sonne MP, van Hall G, Stallknecht B, Dela F, Vaag A: Impact of 9 days of bed rest on hepatic and peripheral insulin action, insulin secretion, and whole-body lipolysis in healthy young male offspring of patients with type 2 diabetes. Diabetes. 2009, 58: 2749-2756. 10.2337/db09-0369.PubMedCentralCrossRefPubMed Alibegovic AC, Højbjerre L, Sonne MP, van Hall G, Stallknecht B, Dela F, Vaag A: Impact of 9 days of bed rest on hepatic and peripheral insulin action, insulin secretion, and whole-body lipolysis in healthy young male offspring of patients with type 2 diabetes. Diabetes. 2009, 58: 2749-2756. 10.2337/db09-0369.PubMedCentralCrossRefPubMed
5.
go back to reference Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1992, 89: 782-788. 10.1172/JCI115656.PubMedCentralCrossRefPubMed Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1992, 89: 782-788. 10.1172/JCI115656.PubMedCentralCrossRefPubMed
6.
go back to reference Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B: Searching for the exercise factor: is IL-6 a candidate?. J Muscle Res Cell Motil. 2003, 24: 113-119. 10.1023/A:1026070911202.CrossRefPubMed Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B: Searching for the exercise factor: is IL-6 a candidate?. J Muscle Res Cell Motil. 2003, 24: 113-119. 10.1023/A:1026070911202.CrossRefPubMed
7.
go back to reference Bortoluzzi S, Scannapieco P, Cestaro A, Danieli GA, Schiaffino S: Computational reconstruction of the human skeletal muscle secretome. Proteins. 2006, 62: 776-792.CrossRefPubMed Bortoluzzi S, Scannapieco P, Cestaro A, Danieli GA, Schiaffino S: Computational reconstruction of the human skeletal muscle secretome. Proteins. 2006, 62: 776-792.CrossRefPubMed
8.
go back to reference Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, Kratchmarova I: Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics. 2010, 9: 2482-2496. 10.1074/mcp.M110.002113.PubMedCentralCrossRefPubMed Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, Kratchmarova I: Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics. 2010, 9: 2482-2496. 10.1074/mcp.M110.002113.PubMedCentralCrossRefPubMed
9.
go back to reference Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM: A PGC1- α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012, 481: 463-468. 10.1038/nature10777.PubMedCentralCrossRefPubMed Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM: A PGC1- α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012, 481: 463-468. 10.1038/nature10777.PubMedCentralCrossRefPubMed
10.
go back to reference Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS: FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012, 61: 1725-1738. 10.1016/j.metabol.2012.09.002.PubMedCentralCrossRefPubMed Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS: FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012, 61: 1725-1738. 10.1016/j.metabol.2012.09.002.PubMedCentralCrossRefPubMed
11.
go back to reference Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, Han HW, Han CK, Zhuang XJ, Lu Y, Li XJ, Yang SY, Li XY: Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013, 59: 557-562. 10.1016/j.jhep.2013.04.030.CrossRefPubMed Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, Han HW, Han CK, Zhuang XJ, Lu Y, Li XJ, Yang SY, Li XY: Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol. 2013, 59: 557-562. 10.1016/j.jhep.2013.04.030.CrossRefPubMed
12.
go back to reference Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG: Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013, 100: 96-101. 10.1016/j.diabres.2013.01.007.CrossRefPubMed Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG: Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013, 100: 96-101. 10.1016/j.diabres.2013.01.007.CrossRefPubMed
13.
go back to reference Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, Tavintharan S, Sum CF, Lim SC: Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013, 27: 365-369. 10.1016/j.jdiacomp.2013.03.002.CrossRefPubMed Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, Tavintharan S, Sum CF, Lim SC: Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013, 27: 365-369. 10.1016/j.jdiacomp.2013.03.002.CrossRefPubMed
14.
go back to reference Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernández-Real JM: Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013, 98: E769-E778. 10.1210/jc.2012-2749.CrossRefPubMed Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernández-Real JM: Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013, 98: E769-E778. 10.1210/jc.2012-2749.CrossRefPubMed
15.
go back to reference Timmons JA, Baar K, Davidsen PK, Atherton PJ: Is irisin a human exercise gene?. Nature. 2012, 488: E9-E11. 10.1038/nature11364.CrossRefPubMed Timmons JA, Baar K, Davidsen PK, Atherton PJ: Is irisin a human exercise gene?. Nature. 2012, 488: E9-E11. 10.1038/nature11364.CrossRefPubMed
16.
go back to reference Boström PA, Graham EL, Georgiadi A, Ma X: Impact of exercise on muscle and nonmuscle organs. IUBMB Life. 2013, 65: 845-850.CrossRefPubMed Boström PA, Graham EL, Georgiadi A, Ma X: Impact of exercise on muscle and nonmuscle organs. IUBMB Life. 2013, 65: 845-850.CrossRefPubMed
17.
go back to reference Colberg SR: Physical activity, insulin action, and diabetes prevention and control. Curr Diabetes Rev. 2007, 3: 176-184. 10.2174/157339907781368986.CrossRefPubMed Colberg SR: Physical activity, insulin action, and diabetes prevention and control. Curr Diabetes Rev. 2007, 3: 176-184. 10.2174/157339907781368986.CrossRefPubMed
18.
go back to reference Hawley JA, Lessard SJ: Exercise training-induced improvements in insulin action. Acta Physiol (Oxf). 2008, 192: 127-135.CrossRef Hawley JA, Lessard SJ: Exercise training-induced improvements in insulin action. Acta Physiol (Oxf). 2008, 192: 127-135.CrossRef
19.
go back to reference Hoene M, Lehmann R, Hennige AM, Pohl AK, Häring HU, Schleicher ED, Weigert C: Acute regulation of metabolic genes and insulin receptor substrates in the liver of mice by one single bout of treadmill exercise. J Physiol. 2009, 587: 241-252. 10.1113/jphysiol.2008.160275.PubMedCentralCrossRefPubMed Hoene M, Lehmann R, Hennige AM, Pohl AK, Häring HU, Schleicher ED, Weigert C: Acute regulation of metabolic genes and insulin receptor substrates in the liver of mice by one single bout of treadmill exercise. J Physiol. 2009, 587: 241-252. 10.1113/jphysiol.2008.160275.PubMedCentralCrossRefPubMed
20.
go back to reference Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, Fujii N, Goodyear LJ, Gotfredsen CF, Brand CL, Lund S: Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes. 2005, 54: 928-934. 10.2337/diabetes.54.4.928.CrossRefPubMed Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, Fujii N, Goodyear LJ, Gotfredsen CF, Brand CL, Lund S: Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes. 2005, 54: 928-934. 10.2337/diabetes.54.4.928.CrossRefPubMed
21.
go back to reference Calegari VC, Zoppi CC, Rezende LF, Silveira LR, Carneiro EM, Boschero AC: Endurance training activates AMP-activated protein kinase, increases expression of uncoupling protein 2 and reduces insulin secretion from rat pancreatic islets. J Endocrinol. 2011, 208: 257-264.PubMed Calegari VC, Zoppi CC, Rezende LF, Silveira LR, Carneiro EM, Boschero AC: Endurance training activates AMP-activated protein kinase, increases expression of uncoupling protein 2 and reduces insulin secretion from rat pancreatic islets. J Endocrinol. 2011, 208: 257-264.PubMed
22.
go back to reference Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011, 11: 98-107. 10.1038/nri2925.CrossRefPubMed Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011, 11: 98-107. 10.1038/nri2925.CrossRefPubMed
23.
go back to reference Dinarello CA, Donath MY, Mandrup-Poulsen T: Role of IL-1betain type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010, 17: 314-321.PubMed Dinarello CA, Donath MY, Mandrup-Poulsen T: Role of IL-1betain type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010, 17: 314-321.PubMed
24.
go back to reference Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi L, Zhang M, Wang X, Cui T, Yang LJ, Tang D: Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014, 63: 514-525. 10.2337/db13-1106.CrossRefPubMed Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi L, Zhang M, Wang X, Cui T, Yang LJ, Tang D: Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014, 63: 514-525. 10.2337/db13-1106.CrossRefPubMed
25.
go back to reference Swick AG, Orena S, O’Connor A: Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism. 2013, 62: 1070-1073. 10.1016/j.metabol.2013.02.012.CrossRefPubMed Swick AG, Orena S, O’Connor A: Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism. 2013, 62: 1070-1073. 10.1016/j.metabol.2013.02.012.CrossRefPubMed
26.
go back to reference Roberts MD, Bayless DS, Company JM, Jenkins NT, Padilla J, Childs TE, Martin JS, Dalbo VJ, Booth FW, Rector RS, Laughlin MH: Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism. 2013, 62: 1052-1056. 10.1016/j.metabol.2013.02.002.PubMedCentralCrossRefPubMed Roberts MD, Bayless DS, Company JM, Jenkins NT, Padilla J, Childs TE, Martin JS, Dalbo VJ, Booth FW, Rector RS, Laughlin MH: Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism. 2013, 62: 1052-1056. 10.1016/j.metabol.2013.02.002.PubMedCentralCrossRefPubMed
27.
go back to reference Polyzos SA, Kountouras J, Shields K, Mantzoros CS: Irisin: a renaissance in metabolism?. Metabolism. 2013, 62: 1037-1044. 10.1016/j.metabol.2013.04.008.CrossRefPubMed Polyzos SA, Kountouras J, Shields K, Mantzoros CS: Irisin: a renaissance in metabolism?. Metabolism. 2013, 62: 1037-1044. 10.1016/j.metabol.2013.04.008.CrossRefPubMed
28.
go back to reference Villarroya F: Irisin, turning up the heat. Cell Metab. 2012, 15: 277-278. 10.1016/j.cmet.2012.02.010.CrossRefPubMed Villarroya F: Irisin, turning up the heat. Cell Metab. 2012, 15: 277-278. 10.1016/j.cmet.2012.02.010.CrossRefPubMed
30.
go back to reference Wu J, Boström P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, Huang K, Tu H, van Marken Lichtenbelt WD, Hoeks J, Enerbäck S, Schrauwen P, Spiegelman BM: Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012, 150: 366-376. 10.1016/j.cell.2012.05.016.PubMedCentralCrossRefPubMed Wu J, Boström P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, Huang K, Tu H, van Marken Lichtenbelt WD, Hoeks J, Enerbäck S, Schrauwen P, Spiegelman BM: Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012, 150: 366-376. 10.1016/j.cell.2012.05.016.PubMedCentralCrossRefPubMed
31.
go back to reference Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF: Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity— correlation with body mass index. Peptides. 2013, 39: 125-130.CrossRefPubMed Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF: Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity— correlation with body mass index. Peptides. 2013, 39: 125-130.CrossRefPubMed
32.
go back to reference Al-Daghri NM, Alkharfy KM, Rahman S, Amer OE, Vinodson B, Sabico S, Piya MK, Harte AL, McTernan PG, Alokail MS, Chrousos GP: Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects. Eur J Clin Invest. 2013, 44: 119-124.CrossRefPubMed Al-Daghri NM, Alkharfy KM, Rahman S, Amer OE, Vinodson B, Sabico S, Piya MK, Harte AL, McTernan PG, Alokail MS, Chrousos GP: Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects. Eur J Clin Invest. 2013, 44: 119-124.CrossRefPubMed
33.
go back to reference Guo F, Moellering DR, Garvey WT: Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-Hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord. 2014, 12: 258-268. 10.1089/met.2013.0128.PubMedCentralCrossRefPubMed Guo F, Moellering DR, Garvey WT: Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-Hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord. 2014, 12: 258-268. 10.1089/met.2013.0128.PubMedCentralCrossRefPubMed
34.
35.
go back to reference Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potentialrole of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003, 100: 8466-8471. 10.1073/pnas.1032913100.PubMedCentralCrossRefPubMed Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potentialrole of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003, 100: 8466-8471. 10.1073/pnas.1032913100.PubMedCentralCrossRefPubMed
36.
go back to reference Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, Brockmann B, Jung R, Wisløff U, Tjønna AE, Raastad T, Hallén J, Norheim F, Drevon CA, Romacho T, Eckardt K, Eckel J: Evidence against a beneficial effect of irisin in humans. PLoS One. 2013, 8: e73680-10.1371/journal.pone.0073680.PubMedCentralCrossRefPubMed Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, Brockmann B, Jung R, Wisløff U, Tjønna AE, Raastad T, Hallén J, Norheim F, Drevon CA, Romacho T, Eckardt K, Eckel J: Evidence against a beneficial effect of irisin in humans. PLoS One. 2013, 8: e73680-10.1371/journal.pone.0073680.PubMedCentralCrossRefPubMed
38.
go back to reference Hofmann T, Elbelt U, Ahnis A, Kobelt P, Rose M, Stengel A: Irisin levels are not affected by physical activity in patients with anorexia nervosa. Front Endocrinol (Lausanne). 2014, 4: 202- Hofmann T, Elbelt U, Ahnis A, Kobelt P, Rose M, Stengel A: Irisin levels are not affected by physical activity in patients with anorexia nervosa. Front Endocrinol (Lausanne). 2014, 4: 202-
Metadata
Title
Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function
Authors
Meili Yang
Peihong Chen
Hua Jin
Xinmiao Xie
Ting Gao
Lili Yang
Xuemei Yu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-133

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.